| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/30/2013 | CN102349899B Application of sophocarpine to preparation of medicament for treating respiratory system diseases caused by coxsackie virus B |
| 01/30/2013 | CN102327615B Bone targeting vector and medicament |
| 01/30/2013 | CN102327605B Preparation process of meningococcal polysaccharide vaccine |
| 01/30/2013 | CN102286084B Gingko biloba defensin, encoding gene and application thereof |
| 01/30/2013 | CN102266419B Preparation method of houttuynia antibacterial cream |
| 01/30/2013 | CN102266387B Medicament for treating foot-and-mouth disease and method for producing medicament for treating foot-and-mouth disease |
| 01/30/2013 | CN102260701B Chicken defensin 9 gene expression vector and preparation method and use thereof |
| 01/30/2013 | CN102258551B Preparation method of andrographis antibacterial cream |
| 01/30/2013 | CN102258539B Bee glue injection for preventing duck plague and preparation method thereof |
| 01/30/2013 | CN102247550B Trollflower compound preparation and preparation method thereof |
| 01/30/2013 | CN102172397B In vivo targeting of dendritic cells |
| 01/30/2013 | CN102085203B Ophthalmic preparation of levofloxacin and prednisolone acetate and preparation method thereof |
| 01/30/2013 | CN101991844B Edwardsiella tarda recombinant subunit vaccine and application thereof |
| 01/30/2013 | CN101979515B Animal rabies virus and vaccine and production method thereof |
| 01/30/2013 | CN101947315B Application of Chinese medicinal bitter apricot seeds in lysozyme sodium alginate microspheres |
| 01/30/2013 | CN101942013B HLA-DR9 restrictive regulatory T cell epitope of Hepatitis B virus core antigen and e antigen and application thereof |
| 01/30/2013 | CN101914160B Composite of hepatitis B virus core antigen and heat shock protein and preparation method and application thereof |
| 01/30/2013 | CN101856328B Ketoconazole foaming agent and preparation method thereof |
| 01/30/2013 | CN101849913B Method for preparing veterinary florfenicol lung targeting gelatin microsphere |
| 01/30/2013 | CN101849907B Nanoemulsion of N-[4-(2,4 dimethoxy phenyl)-5-oxygroup-4,5-dihydro-[1,2] disulfide group-[4,3-b]-6-pyrryl]-3,5-di-trifluoromethyl benzamide and preparation method thereof |
| 01/30/2013 | CN101821268B Tetracyclic compounds for the treatment of hepatitis c |
| 01/30/2013 | CN101811959B Compound separated and extracted from marine penicillium and application thereof |
| 01/30/2013 | CN101781300B Entecavir salt compound, preparation method and medicine application thereof |
| 01/30/2013 | CN101721694B Hircine primary atypical pneumonia combined inactivated vaccine and preparation method thereof |
| 01/30/2013 | CN101664392B Gentamycin sulfate tablets and preparation method thereof |
| 01/30/2013 | CN101613271B 3-alkoxyl-6-carboxyl rhein or officinal salt thereof and preparation method and application thereof |
| 01/30/2013 | CN101547701B Enhancement of antitubercular activity of extracts of salicornia brachiata |
| 01/30/2013 | CN101496897B Vaccine for fish and application |
| 01/30/2013 | CN101353671B Preparation and use of recombinant virus vector gene A3G |
| 01/30/2013 | CN101336978B Extraction method of total flavone of Hovenia dulcisThunb |
| 01/29/2013 | US8362231 RNA interference mediating small RNA molecules |
| 01/29/2013 | US8362058 Bicyclic compound, production and use thereof |
| 01/29/2013 | US8362003 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 01/29/2013 | US8361982 Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell |
| 01/29/2013 | US8361787 Method for expression of small RNA molecules within a cell |
| 01/29/2013 | US8361751 Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost |
| 01/29/2013 | US8361749 Process for preparing variant of Erysipelothrix rhusiopathiae surface protective antigen in E. coli |
| 01/29/2013 | US8361708 Human virus causing severe acute respiratory syndrome (SARS) and uses thereof |
| 01/29/2013 | CA2596794C Tea-based fermentation beverage and tea beverage |
| 01/29/2013 | CA2416137C Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 01/29/2013 | CA2325574C Porcine adenovirus type 3 genome |
| 01/29/2013 | CA2322160C Vaccines, immunotherapeutics and methods for using the same |
| 01/24/2013 | WO2013013187A1 Apolipoprotein e polypeptides and their use |
| 01/24/2013 | WO2013013172A1 Intravaginal devices for drug delivery |
| 01/24/2013 | WO2013012101A1 Fatty acid tripeptide salt and antibacterial composition containing same |
| 01/24/2013 | WO2013012007A1 Anti-virus agent composition |
| 01/24/2013 | WO2013011942A1 Mutant canine madness virus and vaccine |
| 01/24/2013 | WO2013011679A1 Bactericidal agent and method for producing same |
| 01/24/2013 | WO2013011019A1 Pharmaceutical composition for treating a respiratory disease |
| 01/24/2013 | WO2013010869A1 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides btk-inhibitors |
| 01/24/2013 | WO2013010868A1 4 - imidazopyridazin- 1 -yl-benzamides and 4 - imidazotriazin- 1 - yl - benzamides as btk- inhibitors |
| 01/24/2013 | WO2013010300A1 Sequential and repeated application of four or more hiv vector gene vaccines |
| 01/24/2013 | WO2013010260A1 Isolated brachyspira and methods and compositions for expanding and isolating brachyspira |
| 01/24/2013 | WO2013010218A1 Inhibition of clathrin |
| 01/24/2013 | WO2012158552A3 2'-fluoro-6'-methylene carbocyclic nuceosides and methods of treating viral infections |
| 01/24/2013 | WO2012010663A9 2,3,5-trisubstituted thiophene compounds and uses thereof |
| 01/24/2013 | US20130023879 Method for augmenting, reducing, and repairing bone with thermoplastic materials (as amended) |
| 01/24/2013 | US20130023647 Modified human thymic stromal lymphopoietin |
| 01/24/2013 | US20130023585 Neuraminidase Inhibitors |
| 01/24/2013 | US20130023576 Pyrazole Compounds as CRTH2 Antagonists |
| 01/24/2013 | US20130023572 Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating skin diseases |
| 01/24/2013 | US20130023570 Polymorphs of darunavir |
| 01/24/2013 | US20130023565 Influenza a 2009 pandemic h1n1 polypeptide fragments comprising endonuclease activity and their use |
| 01/24/2013 | US20130023564 Piperidinyl derivative as a modulator of chemokine receptor activity |
| 01/24/2013 | US20130023561 Facially Amphiphilic Polymers and Oligomers and Uses Thereof |
| 01/24/2013 | US20130023540 Treatment of mastitis |
| 01/24/2013 | US20130023538 Heteroaryl Derivatives as CFTR Modulators |
| 01/24/2013 | US20130023526 Isoxazolines as Therapeutic Agents |
| 01/24/2013 | US20130023525 Gyrase inhibitors and uses thereof |
| 01/24/2013 | US20130023521 Novel selective inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
| 01/24/2013 | US20130023520 Anaesthetic eye solution and method of use |
| 01/24/2013 | US20130023517 Therapeutic methods employing substituted piperidines which are CCR3 antagonists |
| 01/24/2013 | US20130023512 Compositions for Combating Beta-Lactamase-Medicated Antibiotic Resistance Using Beta-Lactamase Inhibitors Useful For Injection |
| 01/24/2013 | US20130023503 Nk1 antagonists |
| 01/24/2013 | US20130023497 Triazine Derivatives and their Therapeutical Applications |
| 01/24/2013 | US20130023496 Combination Therapy Comprising A CCR5 Antagonist, A HIV-1 Protease Inhibtior and a Pharmacokinetic Enhancer |
| 01/24/2013 | US20130023492 Pharmaceutical compositions comprising plant-based polysaccharides and uses thereof |
| 01/24/2013 | US20130023487 Compounds and compositions for treating infection |
| 01/24/2013 | US20130023483 Template-fixed peptidomimetics with cxcr7 modulating activity |
| 01/24/2013 | US20130023463 Hiv protease inhibiting compounds |
| 01/24/2013 | US20130023462 Lyophilized anti-fungal compositions |
| 01/24/2013 | US20130023461 Oligopeptide compounds and uses thereof |
| 01/24/2013 | US20130022695 Bacterial extract for digestive or urinary tract disorders and process for its preparation |
| 01/24/2013 | US20130022691 Nitric Oxide Generation, Dilution, and Topical Application Apparatus and Method |
| 01/24/2013 | US20130022679 Controlled Release and Taste Masking Oral Pharmaceutical Composition |
| 01/24/2013 | US20130022675 Drug delivery system |
| 01/24/2013 | US20130022668 Biologically Active Taxane Analogs And Methods Of Treatment By Oral Administration |
| 01/24/2013 | US20130022664 E.coli lpfa antigen for prevention and treatment of infectious diseases |
| 01/24/2013 | US20130022651 Hydrogel materials incorporating eluting ceragenin compound |
| 01/24/2013 | US20130022643 Antimicrobial Anti-chafing Chelated Silver Oxide Compound |
| 01/24/2013 | US20130022639 Expression of meningococcal fhbp polypeptides |
| 01/24/2013 | US20130022633 MENINGOCOCCAL fHBP POLYPEPTIDES |
| 01/24/2013 | US20130022632 Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene |
| 01/24/2013 | US20130022631 Vaccine for chikungunya virus infection |
| 01/24/2013 | US20130022629 Modulators of Immunoinhibitory Receptor PD-1, and Methods of Use Thereof |
| 01/24/2013 | US20130022628 Acyl pseudopeptides which carry a functionalized auxiliary arm |
| 01/24/2013 | US20130022619 Methods and compositions for inhibiting hiv transmission |
| 01/24/2013 | US20130022618 Human cytomegalovirus neutralizing antibodies and use thereof |
| 01/24/2013 | US20130022608 FULL-LENGTH IgG IMMUNOGLOBULINS CAPABLE OF RECOGNIZING A HETEROSUBTYPE NEUTRALIZING EPITOPE ON THE HEMAGGLUTININ STEM REGION AND USES THEREOF |
| 01/24/2013 | US20130022604 Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa |